These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 1370737)

  • 1. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
    Wasowska B; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses.
    Wasowska B; Baldwin WM; Howell DN; Sanfilippo F
    Transplantation; 1993 Sep; 56(3):672-80. PubMed ID: 7692630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.
    Wray DW; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of antiidiotypic antibodies and reduced alloantibody responses.
    Downey WE; Baldwin WM; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):160-6. PubMed ID: 2301006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM and IgG alloantibody production by splenocytes and deposition in rat renal allografts are decreased by donor-specific blood transfusion.
    Baldwin WM; Rhoton K; Sanfilippo F
    Transplantation; 1991 Feb; 51(2):481-5. PubMed ID: 1994544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different patterns of sensitization following renal allograft rejection in an inbred rat strain combination.
    Wray DW; Baldwin WM; Sanfilippo F
    Transplantation; 1993 May; 55(5):1132-8. PubMed ID: 8497894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection.
    Ruiz P; Coffman TM; Howell DN; Straznickas J; Scroggs MW; Baldwin WM; Klotman PE; Sanfilippo F
    Transplantation; 1988 Jan; 45(1):1-7. PubMed ID: 3276038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of class I major histocompatibility complex antigens in prolonging the survival of hepatic allografts in the rat.
    Yamaguchi Y; Harland RC; Wyble C; Bollinger RR
    Transplantation; 1989 Jan; 47(1):171-7. PubMed ID: 2643224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.
    Qian Z; Jakobs FM; Pfaff-Amesse T; Sanfilippo F; Baldwin WM
    J Heart Lung Transplant; 1998 May; 17(5):470-8. PubMed ID: 9628565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting outcomes of donor-specific blood transfusion: effectiveness against cell-mediated but not antibody-mediated rejection.
    Yang CP; Shittu E; McManus B; Wood PJ; Bell EB
    Transplantation; 1998 Sep; 66(5):639-45. PubMed ID: 9753346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
    Brauer RB; Baldwin WM; Ibrahim S; Sanfilippo F
    Transplantation; 1995 Jan; 59(2):288-93. PubMed ID: 7839453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of donor-specific blood transfusion enhancement of rat renal allografts on cytotoxic activity and phenotypes of peripheral blood lymphocytes, splenocytes, and graft-infiltrating cells.
    Wasowska B; Baldwin WM; Howell DN; Sanfilippo F
    Transplantation; 1991 Feb; 51(2):451-9. PubMed ID: 1994542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rejection mechanism of rat pancreaticoduodenal allografts with a class I MHC disparity.
    Yamamoto S; Ito T; Nakata S; Nozaki S; Uchikoshi F; Shirakura R; Kamiike W; Miyata M; Matsuda H
    Transplantation; 1994 Apr; 57(8):1217-22. PubMed ID: 7909966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. I. Correlation of graft survival with antidonor IgG antibody subclasses.
    Mhoyan A; Cramer DV; Baquerizo A; Shirwan H
    Transplantation; 1997 Dec; 64(12):1665-70. PubMed ID: 9422399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infiltrating CD45RC- T cells are associated with immunologic unresponsiveness induced by donor class I major histocompatibility complex antigens in rats.
    Yamaguchi Y; Miyanari N; Ichiguchi O; Akizuki E; Matsumura F; Matsuda T; Okabe K; Liang J; Ohshiro H; Mori K; Ogawa M
    Hepatology; 1998 Aug; 28(2):450-8. PubMed ID: 9696011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of donor-specific blood transfusion enhancement of rat renal allografts on host NK cell responses.
    Wasowska B; Howell DN; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jul; 54(1):136-42. PubMed ID: 1631922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of allochimeric proteins to mitigate graft-versus-host and host-versus-graft immune responses to rat small bowel allografts.
    Okamoto M; Stepkowski SM; Wang M; Kahan BD
    Transplantation; 2000 Oct; 70(7):1060-7. PubMed ID: 11045643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FcR blocking activity in serum of actively enhanced rat renal allograft recipients due to IgG anti-class II MHC alloantibody.
    Marshall HE; Bolton EM; Gracie JA; Cocker JE; Sandilands GP; Bradley JA
    Immunology; 1990 Mar; 69(3):379-84. PubMed ID: 2312162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.